• 1005 Citations
  • 17 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Rossi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Aneurysmal Bone Cysts Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Enbucrilate Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Perfusion Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Spine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 1005 Citations
  • 17 h-Index
  • 66 Article
  • 2 Letter
  • 1 Chapter
  • 1 Review article
1 Citation (Scopus)

Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs

Fattizzo, B., Pasquale, R., Carpenedo, M., Cantoni, S., Auteri, G., Gramegna, D., D'Adda, M., Napolitano, M., Consonni, D., Ruggeri, M., Siragusa, S., Rossi, G., Vianelli, N. & Barcellini, W., Oct 1 2019, In : Haematologica. 104, 10, p. e470-e473

Research output: Contribution to journalLetter

Open Access

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

Dodero, A., Guidetti, A., Tucci, A., Barretta, F., Novo, M., Devizzi, L., Re, A., Passi, A., Pellegrinelli, A., Pruneri, G., Miceli, R., Testi, A., Pennisi, M., Di Chio, M. C., Matteucci, P., Carniti, C., Facchetti, F., Rossi, G. & Corradini, P., Apr 1 2019, In : Leukemia. 33, 4, p. 1047-1051 5 p.

Research output: Contribution to journalLetter

Open Access

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment

Trojani, A., Pungolino, E., Molin, A. D., Lodola, M., Rossi, G., D’Adda, M., Perego, A., Elena, C., Turrini, M., Borin, L., Bucelli, C., Malato, S., Carraro, M. C., Spina, F., Latargia, M. L., Artale, S., Spedini, P., Anghilieri, M., Camillo, B. D., Baruzzo, G. & 4 others, De Canal, G., Iurlo, A., Morra, E. & Cairoli, R., Jan 1 2019, In : PLoS One. 14, 7, e0218444.

Research output: Contribution to journalArticle

Open Access
Leukemia, Myeloid, Chronic Phase
myeloid leukemia
ABC transporters
ATP-Binding Cassette Transporters
cell cycle
1 Citation (Scopus)
Follicular Lymphoma
Multicenter Studies
Retrospective Studies
Disease-Free Survival
Maintenance

Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy

Bocchia, M., Candoni, A., Borlenghi, E., Defina, M., Filì, C., Cattaneo, C., Sammartano, V., Fanin, R., Sciumè, M., Sicuranza, A., Imbergamo, S., Riva, M., Fracchiolla, N., Latagliata, R., Caizzi, E., Mazziotta, F., Alunni, G., Di Bona, E., Crugnola, M., Rossi, M. & 22 others, Consoli, U., Fontanelli, G., Greco, G., Nadali, G., Rotondo, F., Todisco, E., Bigazzi, C., Capochiani, E., Molteni, A., Bernardi, M., Fumagalli, M., Rondoni, M., Scappini, B., Ermacora, A., Simonetti, F., Gottardi, M., Lambertenghi Deliliers, D., Michieli, M., Basilico, C., Galeone, C., Pelucchi, C. & Rossi, G., Jan 1 2019, In : Hematological Oncology. 37, 4, p. 447-455

Research output: Contribution to journalArticle

decitabine
Acute Myeloid Leukemia
Drug Therapy
Cytogenetics
Confidence Intervals